J. Goldman & Co’s NEOPHOTONICS CORP NPTN Stock Holding History

J. Goldman & Co’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-182,000	Closed	-$1.2M	–	465
2017 Q4	$1.2M	Buy	+182,000	New	+$1.11M	0.06%	222

Other funds holding NPTN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

J. Goldman & Co's NPTN Position: Q4 2021 in Review

J. Goldman & Co sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 363,402 shares — an estimated $3.17M sold.

J. Goldman & Co first reported a position in NPTN in Q3 2017 and held it in 5 quarters. The position peaked at $5.21M in Q2 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

J. Goldman & Co reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
J. Goldman & Co sold 363,402 NEOPHOTONICS CORP shares in Q4 2021, an estimated $3.17M.
J. Goldman & Co first reported a position in NEOPHOTONICS CORP in Q3 2017 and held it in 5 quarters.
J. Goldman & Co's NEOPHOTONICS CORP position peaked at $5.21M in Q2 2021.
145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on J. Goldman & Co's 13F filing for Q4 2021, filed 14 Feb 2022.